The ophthalmology world is welcoming a new wave of sophisticated implant technology designed to transform diagnosis and treatment.
登壇者プロフィール
Isabel Losantos
Programme Manager, Medical Technologies
Isabel has over 15 years experience in medical devices and is currently working with colleagues to provide regulatory insights to help current and prospective clients.
この筆者のインサイト
Overcoming regulatory hurdles for ophthalmic combination products
Regulatory approval for ophthalmic combination products is like gold dust. This instalment in our ophthalmology series walks you through the challenges and helps plot a route to market